Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
March-2015 Volume 33 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2015 Volume 33 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer

  • Authors:
    • Jiufeng Tan
    • Xuefei Jin
    • Rui Zhao
    • Xin Wei
    • Yan Liu
    • Xiangbo Kong
  • View Affiliations / Copyright

    Affiliations: Department of Urology, China-Japan Union Hospital, Jilin University, Changchun, Jilin 130033, P.R. China, Department of Otolaryngology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
  • Pages: 1512-1518
    |
    Published online on: December 19, 2014
       https://doi.org/10.3892/or.2014.3684
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Prostate cancer is the most common malignancy in males and easily develops to be aggressive which is closely related to the chronic inflammatory tumor microenvironment in situ. This study aimed to assess the immunoglobulin G (IgG) subclass of B cells and explore their interactions with T follicular helper (Tfh) subsets in prostate cancer patients. The percentages of peripheral blood naïve B cells, memory B cells and mature B cells, as well as Tfh1, Tfh2 and Tfh17 cells were analyzed or sorted by FACSAria. The ratios of the different IgG subclasses (IgG1, IgG2, IgG3 and IgG4) were detected by ELISA, and the expression levels of CXCR3 and CCR6 were measured using RT-PCR and western blot analysis. Meanwhile a co-culture system of B and Tfh cells was to assess the effect of each Tfh subset on the antibody subclass switching of B cells in vitro. We observed higher percentages of 3 Tfh subsets and IgG4+ B cells in the patients with prostate cancer than that in the health controls and proved a positive correlation between Tfh2 and IgG4+ B cells. Then we verified that IL-4, IL-6, IL-10 and prostaglandin E2 (PGE2) effectively promoted antibody class switching of B cells, which may be mediated by inducing Tfh2 cells, yet the study was not completely dependent on Tfh cells. The results provide evidence of the B cell response to an immune suppressive environment by evaluating IgG4 antibodies, and established a relationship between IgG4+ B cells and Tfh2 cells. Clarification of lymphocyte functions in the inflammatory microenvironment of tumors will be of potential therapeutic value.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Jemal A, Thomas A, Murray T and Thun M: Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002. View Article : Google Scholar : PubMed/NCBI

2 

Heinlein CA and Chang C: Androgen receptor in prostate cancer. Endocr Rev. 25:276–308. 2004. View Article : Google Scholar : PubMed/NCBI

3 

De Marzo AM, Platz EA, Sutcliffe S, Xu J, Grönberg H, Drake CG, Nakai Y, Isaacs WB and Nelson WG: Inflammation in prostate carcinogenesis. Nat Rev Cancer. 7:256–269. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Mantovani A, Allavena P, Sica A and Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Sfanos KS and De Marzo AM: Prostate cancer and inflammation: the evidence. Histopathology. 60:199–215. 2012. View Article : Google Scholar : PubMed/NCBI

6 

Sethi G, Shanmugam MK, Ramachandran L, Kumar AP and Tergaonkar V: Multifaceted link between cancer and inflammation. Biosci Rep. 32:1–15. 2012. View Article : Google Scholar

7 

Salman H, Ori Y, Bergman M, Djaldetti M and Bessler H: Human prostate cancer cells induce inflammatory cytokine secretion by peripheral blood mononuclear cells. Biomed Pharmacother. 66:330–333. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI

9 

Sciarra A, Mariotti G, Salciccia S, Autran Gomez A, Monti S, Toscano V and Di Silverio F: Prostate growth and inflammation. J Steroid Biochem Mol Biol. 108:254–260. 2008. View Article : Google Scholar

10 

Grivennikov SI, Greten FR and Karin M: Immunity, inflammation and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Sha W, Olesch C, Hanaka H, Rådmark O, Weigert A and Brüne B: Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation. Int J Cancer. 133:1578–1588. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Donkor MK, Sarkar A, Savage PA, Franklin RA, Johnson LK, Jungbluth AA, Allison JP and Li MO: T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine. Immunity. 35:123–134. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Jefferis R: Isotype and glycoform selection for antibody therapeutics. Arch Biochem Biophys. 526:159–166. 2012. View Article : Google Scholar : PubMed/NCBI

14 

Papadea C and Check IJ: Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic and clinical aspects. Crit Rev Clin Lab Sci. 27:27–58. 1989. View Article : Google Scholar

15 

Harada K, Shimoda S, Kimura Y, Sato Y, Ikeda H, Igarashi S, Ren XS, Sato H and Nakanuma Y: Significance of (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology. 56:157–164. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Cipponi A, Mercier M, Seremet T, Baurain JF, Théate I, van den Oord J, Stas M, Boon T, Coulie PG and van Baren N: Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res. 72:3997–4007. 2012. View Article : Google Scholar : PubMed/NCBI

17 

Karagiannis P, Gilbert AE, Josephs DH, Ali N, Dodev T, Saul L, Correa I, Roberts L, et al: IgG4 subclass antibodies impair antitumor immunity in melanoma. J Clin Invest. 123:1457–1474. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Gilbert AE, Karagiannis P, Dodev T, Koers A, Lacy K, Josephs DH, Takhar P, et al: Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies. PLoS One. 6:e193302011. View Article : Google Scholar : PubMed/NCBI

19 

Platts-Mills TA, Woodfolk JA, Erwin EA and Aalberse R: Mechanisms of tolerance to inhalant allergens: the relevance of a modified Th2 response to aller gens from domestic animals. Springer Semin Immunopathol. 25:271–279. 2004. View Article : Google Scholar : PubMed/NCBI

20 

Satoguina JS, Weyand E, Larbi J and Hoerauf A: T regulatory-1 cells induce IgG4 production by B cells: role of IL-10. J Immunol. 174:4718–4726. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Crotty S: Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 29:621–663. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M and Förster R: Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles and support immunoglobulin production. J Exp Med. 192:1545–1552. 2000. View Article : Google Scholar : PubMed/NCBI

23 

McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N and McHeyzer-Williams MG: Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol. 21:266–273. 2009. View Article : Google Scholar : PubMed/NCBI

24 

Davidson A and Aranow C: Lupus nephritis: lessons from murine models. Nat Rev Rheumatol. 6:13–20. 2010. View Article : Google Scholar

25 

Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, Foucat E, Dullaers M, et al: Human blood CXCR5(+) CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 34:108–121. 2011. View Article : Google Scholar : PubMed/NCBI

26 

Traggiai E, Becker S, Subbarao K, Kolesnikova L, Uematsu Y, Gismondo MR, Murphy BR, Rappuoli R and Lanzavecchia A: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med. 10:871–875. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Neild GH, Rodriguez-Justo M, Wall C and Connolly JO: Hyper-IgG4 disease: report and characterization of a new disease. BMC Med. 4:232006. View Article : Google Scholar

28 

Stone JH, Zen Y and Deshpande V: IgG4-related disease. N Engl J Med. 366:539–551. 2012. View Article : Google Scholar : PubMed/NCBI

29 

Bentebibel SE, Schmitt N, Banchereau J and Ueno H: Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc Natl Acad Sci USA. 108:E488–E497. 2011. View Article : Google Scholar

30 

Aalberse RC and Schuurman J: IgG4 breaking the rules. Immunology. 105:9–19. 2002. View Article : Google Scholar : PubMed/NCBI

31 

Aalberse RC, Stapel SO, Schuurman J and Rispens T: Immunoglobulin G4: an odd antibody. Clin Exp Allergy. 39:469–477. 2009. View Article : Google Scholar : PubMed/NCBI

32 

French M: Serum IgG subclasses in normal adults. Monogr Allergy. 19:100–107. 1986.PubMed/NCBI

33 

Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S, Korets L, Lam J, Tawfik D, DeNardo DG, Naldini L, de Visser KE, De Palma M and Coussens LM: FcRgamma activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell. 17:121–134. 2010. View Article : Google Scholar : PubMed/NCBI

34 

DiLillo DJ, Yanaba K and Tedder TF: B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol. 184:4006–4016. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Zhao E, Wang L, Dai J, Kryczek I, Wei S, Vatan L, Altuwaijri S, Sparwasser T, Wang G, Keller ET and Zou W: Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer. Oncoimmunology. 1:152–161. 2012. View Article : Google Scholar : PubMed/NCBI

36 

English K, Tonlorenzi R, Cossu G and Wood KJ: Mesoangioblasts suppress T Cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells Dev. 22:512–523. 2013. View Article : Google Scholar :

37 

Chen YL, Chang MC, Chen CA, Lin HW, Cheng WF and Chien CL: Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responses. PLoS One. 7:e471902012. View Article : Google Scholar : PubMed/NCBI

38 

Miyara M and Sakaguchi S: Natural regulatory T cells: mechanisms of suppression. Trends Mol Med. 13:108–116. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tan J, Jin X, Zhao R, Wei X, Liu Y and Kong X: Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer. Oncol Rep 33: 1512-1518, 2015.
APA
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., & Kong, X. (2015). Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer. Oncology Reports, 33, 1512-1518. https://doi.org/10.3892/or.2014.3684
MLA
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., Kong, X."Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer". Oncology Reports 33.3 (2015): 1512-1518.
Chicago
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., Kong, X."Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer". Oncology Reports 33, no. 3 (2015): 1512-1518. https://doi.org/10.3892/or.2014.3684
Copy and paste a formatted citation
x
Spandidos Publications style
Tan J, Jin X, Zhao R, Wei X, Liu Y and Kong X: Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer. Oncol Rep 33: 1512-1518, 2015.
APA
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., & Kong, X. (2015). Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer. Oncology Reports, 33, 1512-1518. https://doi.org/10.3892/or.2014.3684
MLA
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., Kong, X."Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer". Oncology Reports 33.3 (2015): 1512-1518.
Chicago
Tan, J., Jin, X., Zhao, R., Wei, X., Liu, Y., Kong, X."Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer". Oncology Reports 33, no. 3 (2015): 1512-1518. https://doi.org/10.3892/or.2014.3684
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team